Citius Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.

About CTXR

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. 

CEO
Leonard L. Mazur
CEOLeonard L. Mazur
Employees
22
Employees22
Headquarters
Cranford, New Jersey
HeadquartersCranford, New Jersey
Founded
2007
Founded2007
Employees
22
Employees22

CTXR Key Statistics

Market cap
117.38M
Market cap117.38M
Price-Earnings ratio
-2.88
Price-Earnings ratio-2.88
Dividend yield
—
Dividend yield—
Average volume
1.47M
Average volume1.47M
High today
$0.7544
High today$0.7544
Low today
$0.70
Low today$0.70
Open price
$0.74
Open price$0.74
Volume
1.31M
Volume1.31M
52 Week high
$1.62
52 Week high$1.62
52 Week low
$0.60
52 Week low$0.60
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.